Resistencia a insulina en pequeños para la edad gestacional tratados con hormona de crecimiento. Estudio observacional
López Siguero, Juan P.
Martínez-Aedo, Maria J.
Bermúdez de la Vega, José A.
Lechuga-Sancho, Alfonso M.
MetadataShow full item record
Background. In children born small for gestational age (SGA), the relationship between growth hormone (GH) treatment and insulin resistance [IR] has been investigated for a short-term period, being necessary a longer observation. Objectives. Evaluate the long-term (10 years) effect of the GH administered to SGA-children on IR and the safety during treatment. Methods. Multicenter observational study in SGA children receiving GH treatment in Spain (stratified by Tanner stage and age at GH onset [two groups: ≤6 years; >6 years]). Analyzed variables (yearly) included auxologic (growth velocity [GV]), metabolic (IGF-1, homeostatic model assessment- IR [HOMA-IR]), and safety ones. Data were collected prospectively since study approval (2007) and retrospectively from GH treatment onset (2005- 2007). Results. Interim analysis (6 years' follow-up) of 389 SGA children (369 Tanner I) from 27 centers. Mean age (SD) at GH treatment onset): 7.2 (3.1) years. IGF-1 (SDS) and HOMA-IR tended to increase until the sixth year with significant differences at the first year, and remaining stable thereafter (within normal ranges). Height (SDS) increased significantly (basal: -3.0; sixth year: -1.5); being the maximum GV at the first year (8.60 cm/year, with higher values in the ≤6 years group). Twenty-one adverse events were reported, two of them serious: type 2 diabetes, and osteonecrosis. Conclusions. The HOMA-IR increased significantly in SGA children during the first year of GH treatment, remaining stable later on, within normal ranges in any case. Our sixth-year data suggest that long-term GH treatment does not promote IR, is well tolerated, safe, and effective
Is part ofRevista Española de Endocrinologia Pediátrica, 2020, vol. 11, núm. 2, p. 4-14
European research projects
Showing items related by title, author, creator and subject.
de Hollanda, Ana; Lecube Torelló, Albert; Rubio, Miguel Ángel; Sánchez Peña, Enric; Vilarrasa, Núria; Gregorio Oliva, José; Fernández-Soto, María Luisa; Salas-Salvadó, Jordi; Ballesteros-Pomar, María D.; Ciudin, Andreea; Torres, Ferran; Vidal, Concepción; Morales, María José; Valdés, Sergio; Pellitero, Silvia; Miñambres, Inka; Masmiquel, Lluís; Goday, Albert; Suarez, Lorena; Flores, Liliam; Bueno Díez, Marta; Caixàs, Assumpta; Bretón, Irene; Cámara, Rosa; Olbeyra, Romina; Penso, Rona; de la Cruz, María José; Simó-Servat, Andreu; Pereyra-García, Francisca María; López-Mezquita, Elena Teresa; Gils, Anna; Fidilio, Enzamaria; Bandrés, Orosia; Martínez, Ángel; Abuín, Jose; Marques-Pamies, Montserrat; Tuneu, Laura; Arteaga, Magdalena; Castañer, Olga; Goñi, Fernando; Arrizabalaga, Cristina; Botana, Manuel Antonio; Calañas, Alfonso (MDPI, 2020)Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after ...
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study Garcia-Alfonso, Pilar; Chaves, Manuel; Muñoz, Andrés; Salud Salvia, Maria Antonieta; García-Gonzalez, Maria; Grávalos, Cristina; Massuti, Bartomeu; González-Flores, Encarna; Queralt, Bernardo; López-Ladrón, Amelia; Losa, F.; Gómez, Maria Jose; Oltra, Amparo; Aranda, Enrique (BioMed Central, 2015)Background: The optimal sequence of chemotherapeutic agents is not firmly established for the treatment of metastatic colorectal cancer (mCRC). This phase II multi-centre study investigated the efficacy and tolerability ...
Fernandez Jaén, Tomas; Álvarez Rey, Guillermo; Angulo, Francisco; Ardevol Cuesta, Jordi; Arriaza Loureda, Rafael; Ávila España, Fernando; Ayala, Juan; Balius Matas, Ramón; Baró Pazos, Fernando; Dios Beas Jiménez, Juan de; Candel Rosell, Jorge; Cobián Fernandez, César; Doñoro Cuevas, Mª del Pilar; Esparza Ros, Francisco; Espejo Colmenero, Josefina; Fernández de Prado, Jorge; García Cota, Juan José; Garrido González, Jose Ignacio; Gonzalez de Vega, Carlos; González Santander, Manuela; Herrador Munilla, Miguel Ángel; Ivorra Ruiz, Francisco; Jiménez Díaz, Fernando; Maestro Fernandez, Antonio; Manonelles Marqueta, Pedro; Muñoz Benito, Juan Jose; Olivé Vilás, Ramón; Pedret, Carles; Peirau i Terés, Xavier; Peña Amaro, José; Puigdellivoll Grifell, Jordi; Pérez San Roque, Juan; Ramírez Parenteu, Christophe; Ribas Serna, Juan; Rodas, Gil; Sánchez Álvarez, Mikel; Sanchez Marchori, Carlos; Til Perez, Lluis; Ureña Durán, Rosario; Valle Soto, Miguel de; Villalón Alonso, José María; Guillen García, Pedro; Spanish Group for Tendon Consensus (Sage, 2017)On October 15, 2016, experts met at Clínica CEMTRO in Madrid, Spain, under the patronage of the Spanish Society for Sports Traumatology (SETRADE), the Spanish Society of Sports Medicine (SEMED), the Spanish Association of ...